Open Nav

David Portman

Chief Executive Officer

Sermonix Pharmaceuticals LLC

Dr. David Portman is founder and CEO of Sermonix Pharmaceuticals where he leads the lasofoxifene development program for the treatment of advanced breast cancer. He was the Founder and is Director Emeritus of the Columbus Center for Women's Health Research as well as Adjunct Instructor in the Department of Obstetrics and Gynecology at The Ohio State University College of Medicine. Dr. Portman has conducted over 140 clinical studies in Selective Estrogen Receptor Modulators (SERMs), including acting as principal investigator in Pfizer’s non-oncology osteoporosis and vulvovaginal atrophy development programs for lasofoxifene. He has published dozens of articles in numerous peer-reviewed medical journals including the American Journal of Obstetrics and Gynecology, Menopause, Journal of Sexual Medicine, Obstetrics and Gynecology, and Contraception.

This speaker's sessions: